Respiratory and sleep Archives - Page 5 of 14

Clinical Articles

Eco-friendly inhalers vs optimal care: lessons from overseas

UK Drs were pushed to change inhalers & patients paid the price. How we can avoid that mistake – & balance environmental concerns

Expert/s: Healthed

Podcasts

Detection, assessment and management of pulmonary fibrosis

Associate Professor Nicole Goh outlines the key features of pulmonary fibrosis

Videos

Pulmonary fibrosis – What GPs need to know about detection, assessment and management

Pulmonary fibrosis is common but often diagnosed late. A/Prof Nicole Goh discusses diagnosis, treatments, prognosis, and GP management.

Podcasts

Whooping cough – What you need to know

In today’s podcast, Prof Nigel Crawford discusses whooping cough symptoms, complications, and the importance of vaccination, especially for pregnant women.

Podcasts

The impacts of non-consensual switching of inhaler therapy

Listen to expert Prof Omar Usmani on inhaler therapy choices, choosing the right device for each patient and prioritising education to prevent complications.

Podcasts

Chronic wet cough in children

In today's podcast, Prof Anne Chang discusses chronic wet cough in children, investigation, treatment and underlying immune deficiencies.

Videos

Beclometasone/formoterol/glycopyrronium pMDI for severe asthma

In this Product Explainer, Respiratory Physician Dr Andrew Scroop explains the role of beclometasone/ formoterol/ glycopyrronium pressurised metered dose inhalers (pMDIs) for maintenance treatment in adult patients with uncontrolled asthma despite treatment with an ICS and a LABA with a history of exacerbations.

Clinical Articles

GLP-1s for sleep apnoea – are they a game-changer?

How the advent of effective obesity drugs could change how we manage OSA – and what it means for CPAP…

Clinical Articles

Sleep apnoea: How to assess driving risk

Sleep expert Dr Anup Desai runs through assessing the risks and responsibilities.

Videos

Fluticasone furoate, umeclidinium and vilanterol once-daily single inhaler triple therapy

In this Product Explainer, Respiratory Physician Dr Adrian Barnett explains the role of fluticasone furoate, umeclidinium and vilanterol once-daily single inhaler triple therapy for the maintenance treatment of asthma in adult patients who are not adequately controlled with an ICS+LABA (5 mins).This educational activity was developed by Healthed at the request of and with funding from GSK.PM-AU-FVU-PPTX-230007 Approved July 2023.

Podcasts

Sleep disorders and weight management

Prof Brendon Yee presents the latest evidence and recommendations for the use of GLP-1 agonists.

Podcasts

Triple therapy in asthma – Case studies in primary care

Dr Andrew Scroop presents two case studies to demonstrate the evidence-based approach for triple therapy in asthma.

Respiratory and sleep

Eco-friendly inhalers vs optimal care: lessons from overseas

UK Drs were pushed to change inhalers & patients paid the price. How we can avoid that mistake – & balance environmental concerns

Detection, assessment and management of pulmonary fibrosis

Associate Professor Nicole Goh outlines the key features of pulmonary fibrosis

Pulmonary fibrosis – What GPs need to know about detection, assessment and management

Pulmonary fibrosis is common but often diagnosed late. A/Prof Nicole Goh discusses diagnosis, treatments, prognosis, and GP management.

Whooping cough – What you need to know

In today’s podcast, Prof Nigel Crawford discusses whooping cough symptoms, complications, and the importance of vaccination, especially for pregnant women.

The impacts of non-consensual switching of inhaler therapy

Listen to expert Prof Omar Usmani on inhaler therapy choices, choosing the right device for each patient and prioritising education to prevent complications.

Chronic wet cough in children

In today's podcast, Prof Anne Chang discusses chronic wet cough in children, investigation, treatment and underlying immune deficiencies.

Beclometasone/formoterol/glycopyrronium pMDI for severe asthma

GLP-1s for sleep apnoea – are they a game-changer?

How the advent of effective obesity drugs could change how we manage OSA – and what it means for CPAP…

Sleep apnoea: How to assess driving risk

Sleep expert Dr Anup Desai runs through assessing the risks and responsibilities.

Fluticasone furoate, umeclidinium and vilanterol once-daily single inhaler triple therapy

Sleep disorders and weight management

Prof Brendon Yee presents the latest evidence and recommendations for the use of GLP-1 agonists.

Triple therapy in asthma – Case studies in primary care

Dr Andrew Scroop presents two case studies to demonstrate the evidence-based approach for triple therapy in asthma.

Get the app

Site

Company

Connect

Legal

Healthed

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.

Respiratory and sleep

UK Drs were pushed to change inhalers & patients paid the price. How we can avoid that mistake – & balance environmental concerns

Associate Professor Nicole Goh outlines the key features of pulmonary fibrosis

Pulmonary fibrosis is common but often diagnosed late. A/Prof Nicole Goh discusses diagnosis, treatments, prognosis, and GP management.

In today’s podcast, Prof Nigel Crawford discusses whooping cough symptoms, complications, and the importance of vaccination, especially for pregnant women.

Listen to expert Prof Omar Usmani on inhaler therapy choices, choosing the right device for each patient and prioritising education to prevent complications.

In today's podcast, Prof Anne Chang discusses chronic wet cough in children, investigation, treatment and underlying immune deficiencies.

How the advent of effective obesity drugs could change how we manage OSA – and what it means for CPAP…

Sleep expert Dr Anup Desai runs through assessing the risks and responsibilities.

Prof Brendon Yee presents the latest evidence and recommendations for the use of GLP-1 agonists.

Dr Andrew Scroop presents two case studies to demonstrate the evidence-based approach for triple therapy in asthma.

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Extra Details

Healthed

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.